LumiraDx Sells Point of Care Technology Platform to Roche
Roche will pay a purchase price of USD 295 million (subject to customary closing adjustments) and an additional payment of up to USD 55 million for the reimbursement of amounts to fund the point-of-care diagnostics platform business until the closing of the acquisition.
The transaction will be completed only after fulfilling certain conditions, including antitrust and regulatory approvals. It is expected that the transaction will close by mid-2024. Roche's acquisition of LumiraDx's innovative point-of-care technology will help Roche expand its diagnostic testing globally. The sale proceeds will be used to repay certain amounts outstanding under the Company’s senior secured loan agreement. The Company or its shareholders will not receive any sale proceeds.
The appointment of the administrators and the sale to Roche mark the end of LumiraDx’s previously announced strategic review process led by Goldman Sachs & Co. LLC. MarketsandMarkets’ analysts estimate that the Lateral Flow Assays market is expected to grow at a CAGR of 2.0% to reach $22.6 billion by 2027. The key players in the market include Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, Danaher Corporation, and Becton, Dickinson and Company. The market growth factors include the increasing prevalence of infectious diseases, the rising incidence of target conditions, and the growing demand for home-based POC devices.
MarketsandMarkets Industry News Desk
Editor's Pick

Healthcare
MiniMed™ 780G & Simplera Sync™: Smarter Tech, Simpler Lives for Diabetes Patients
Information and Communication Technology
Google Veo 2, Raising the Bar for AI Video Generation.jpg)
Automotive & Transportation
Trump’s Reciprocal Tariffs Stir Ripples Across the Automotive IndustryPODCASTS

Sustainable Digital Transformation & Industry 4.0
Sanjay Kaul, President-Asia Pacific & Japan, Cisco, and host Aashish Mehra, Chief Research Officer, MarketsandMarkets, in conversation on unraveling 'Sustainable Digital Transformation and Industry 4.0'
11 July 2023|S2E12|Listen Now

Generative AI
Prasad Joshi, Senior Vice President-Emerging Technology Solutions, Infosys, and host, Vinod Chikkareddy, CCO, MarketsandMarkets, in exploring the recent advances in AI and the generative AI space.
7 Nov 2023|S2E13|Listen Now
Global Lateral Flow Assay Market


Download Whitepaper
LumiraDx has signed a definitive agreement with Roche to sell certain companies of the LumiraDx group that are involved in the point-of-care diagnostics platform business
Roche will pay a purchase price of USD 295 million (subject to customary closing adjustments) and an additional payment of up to USD 55 million for the reimbursement of amounts to fund the point-of-care diagnostics platform business until the closing of the acquisition.
